← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

EVP and Chief Medical Officer Matthew L Sherman sold $48K of Deciphera Pharmaceuticals, Inc.

Sold$48,455
$18.73Price
2,587Shares
−3%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Mon, Oct 3. Filed Wed, Oct 5, 12:05 PM ET, during the session. Not investment advice.